Arthur L. Caplan, STAT

Arthur L. Caplan

STAT

New York, NY, United States

Contact Arthur

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • STAT
  • Washington Post
  • NBC News
  • Stamford Advocate
  • leapsmag
  • The Boston Globe
  • Forbes
  • Poynter
  • PLOS
  • TODAY

Past articles by Arthur:

Breakthrough Therapies Act: Good idea, wrong solution

Despite the good intentions of the Breakthrough Therapies Act, there are multiple flaws in it, each of which limits the potential to meaningfully help individuals in need. → Read More

Medicare was right to limit coverage for pricey new Alzheimer’s drug

We need to recommit to demanding strong proof that medical treatments work. → Read More

Covid vaccine refusal removes Boston patient from heart transplant waitlist. As it should.

Hospitals rightly place considerable importance on which recipients are likely to live longer and better. → Read More

Here are some questions about the pig heart transplant that people actually should be asking

Put aside the patient's newly revealed criminal record, which is not morally relevant in selecting a subject in a dangerous experiment with a high likelihood of failure. There are other, more relevant things to discuss. → Read More

Opinion: I’m an ethics expert. CT needs vaccine passports.

No one is making you vaccinate, but for those who do, a QR code on your phone makes... → Read More

Next boy up: Kids continue to die on high school football fields

Even as the Covid-19 pandemic ravaged the U.S., youths across the country died and were injured playing football. → Read More

Do we need vaccine exemption boards?

Today we have nothing like the draft boards of yore to assess claims to be exempted from a mandate requiring vaccination against Covid-19. → Read More

“You First”: Who Will Be Front in Line to Get a COVID Vaccine?

The general public won’t get access for many, many months → Read More

Is it ethical to give someone coronavirus to create a vaccine? Yes

The political spin promising a quick vaccine for COVID-19 is false. The average time to make a vaccine is 20 years. → Read More

Please Don’t Take Prescription Drug Advice from Kim Kardashian

Paying Unqualified Celebs to Market Drugs Is a Harmful Practice → Read More

Trump's 'Right To Try' Push Would Only Punish The Seriously Ill

The president has called for legislation to give patients access to investigational drugs, but the holdup in the current system is drug companies, not the FDA, and the law he is seeking would make those companies less likely to participate. → Read More

The media needs to do more to elevate a national conversation about ethics

Presidents, Olympians, congressional leaders, judges, university professors, religious leaders, media stars, military leaders, police, professional → Read More

Football-related injuries extend far beyond concussions

In football, concussions matter. But other injuries that make it difficult to walk or cause chronic pain are also high prices to pay for playing the game. → Read More

Veterans with genital injuries aren’t getting the care they deserve

It’s time to acknowledge the impact on our veterans’ intimacy, sexual function, reproduction and self-image. → Read More

Mainstream medicine is partly to blame for the 'treatments' Goop promotes

Some of the most prestigious hospitals and clinics in North America offer many of the same unproven "treatments" that Gwyneth Paltrow and Goop promote. → Read More

Health disparities and clinical trial recruitment: Is there a duty to tweet?

While it is well known that the homogeneity of clinical trial participants often threatens the goal of attaining generalizable knowledge, researchers often cite issues with recruitment, including a lack of interest from participants, shortages of resources, or difficulty accessing particular populations, to explain the lack of diversity within sampling. It is proposed that social media might… → Read More

The FDA isn’t the only roadblock to accessing to new therapies

To speed access to new drugs, patient advocacy groups need to look beyond the FDA and incorporate payers into their strategies for change. → Read More

Voters barely worry about their own health. Do they really care about the president’s?

Historically, candidates haven't needed to be all that healthy to be elected. → Read More

Extreme athletes take major risks. Should we pay for them?

It isn't fair to expect society to pick up the tab for athletic misadventures. → Read More

Ethicist: There's Nothing Fishy About GMO Salmon

Bioethicist Arthur Caplan has thought long and hard about GM fish. He thinks you should buy it. → Read More